标签与使用说明书:语言、必备项与常见退件点
Updated: 2026-11-09 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Cambodia’s language requirements for labelling and for submission documents operate at two different levels:
- Labelling: medical devices must be labelled in Khmer or English;
- Submission documents (including the technical dossier): should be printed clearly in English, French or Khmer; documents in any other language must carry, in addition to the original, a complete certified or notarised translation, and the certification of the translation must be done at the Cambodian embassy or consulate nearest to the country where the document was produced; the applicant or marketing authorisation holder is responsible for the accuracy of the translation.
Under Prakas No. 1258, the mandatory label content includes at least: the product name, the name of the manufacturing organisation and the country of manufacture, the address and country of the party responsible for the product, the manufacturing date/batch number/expiry date, storage conditions, precautions and restrictions on use, and other necessary information. In addition, medical devices that differ in appearance or trade name and are produced by different manufacturers must be registered separately.
GRZAN note: label language is Khmer or English (a 2-way choice); submission document language is English, French or Khmer (a 3-way choice); mandatory label items number at least 6 categories.
2. Legal basis
| Legal instrument | Number / reference | Date | Provisions |
|---|---|---|---|
| Prakas No. 1258 on Medical Device Registration Procedures | Prakas No. 1258 | 8 November 2012 | label language (Khmer or English); mandatory label content; devices with different appearance or trade names registered separately |
| ASEAN Medical Device Directive (AMDD) | signed by the 10 ASEAN member states | Article 22: entered into force 1 January 2015 | Article 10 (labelling per member state requirements, Annex 7 may be used); Annex 4 CSDT Module E |
| Guidelines for the Registration of Therapeutic Products in Cambodia | DDF, 190 pages | 1 August 2019 | Section 2.3: language and translation certification requirements |
3. Expert insights
- Label language and document language are two distinct requirements; mixing them up causes errors on both fronts. Labels accept only Khmer or English; submission documents accept English, French or Khmer. Using French for the label because “documents may be in French”, or assuming that all documents may be supplied in English only because “labels may be in English”, will each trigger rejection.
- The “party responsible for the product” is a mandatory label item, which directly constrains the local entity’s information disclosure. Prakas No. 1258 requires the label to state the address and country of the party responsible for the product. Because overseas manufacturers cannot file on their own and a licensed local company acts as applicant, the label will normally need to carry the local responsible party’s details. When the local representative changes, the label must be updated in step — the item most easily missed in change management.
- AMDD Article 10 returns labelling specifics to the member states. Cambodia’s labelling rules therefore rest on domestic requirements, not on Annex 7. With Cambodia’s labelling rules not fully public, the prudent approach is to satisfy both the mandatory items listed in Prakas No. 1258 and the structure of Annex 7, taking the union of the two.
4. Practical recommendations
- Submit label artwork with the dossier, identical word for word to the online entry and to the labelling section of the technical dossier. Any mismatch among the three is a high-frequency rejection point. Generate all three outputs from one master label file.
- Prepare label artwork separately for every SKU. Cambodia does not permit product grouping; different models, specifications, appearances or trade names must be registered separately, so labels must also be prepared model by model — one generic artwork will not do.
- Bring “responsible party” changes into the change management process. A change of local representative, address or contact details triggers a labelling update obligation, to be processed together with the registration certificate variation.
5. Verification checklist
- □ Labels in Khmer or English
- □ Labels contain all 6 categories of mandatory items (name, manufacturing organisation and country, responsible party’s address and country, date/batch number/expiry, storage conditions, precautions)
- □ Submission documents in English, French or Khmer
- □ Originals not in English/French/Khmer accompanied by notarised complete translations
- □ Label artwork prepared separately for every SKU
- □ Label artwork identical word for word to the online entry and to Module E of the technical dossier
Regulatory information verified as of 29 October 2026.
In Southeast Asian markets, GRZAN’s core capabilities concentrate on three points. First, distinguishing the legislative progress of dedicated medical device laws across member states — Singapore, Malaysia, Thailand, Indonesia, the Philippines and Vietnam have each established written device regulatory frameworks, whereas Cambodia still has no dedicated Medical Device Law; the current rules are assembled from three layers: the registration-number legal basis provided by the 1996 Law on Drug Management and its 2007 amendment, the classification and procedures provided by Prakas No. 1258 of 2012, and the technical framework provided by the ASEAN Medical Device Directive. Compliance certainty is therefore markedly lower than in markets that have completed legislation. Second, local authorised representative services: GRZAN can act as the manufacturer’s statutory representative in Cambodia, undertaking registration submission, regulatory communication and post-market reporting obligations, and assisting with the practical requirements for a Cambodian registered pharmacist and a drug import-export enterprise licence. Third, quality system and testing support: helping establish a quality management system that meets ISO 13485 requirements and organising the technical dossier under the ASEAN Common Submission Dossier Template (CSDT).
Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us